Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue — Thornton, Colorado

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue is a clinical research site located in Thornton, Colorado, United States 80233.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Thornton

Browse all research sites in Colorado · View every site in Thornton

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue conducted?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue accredited by Crixeo Clinical Trials?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.